D-0418-2022 Class II Terminated
FDA drug recall D-0418-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 3930 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 2, 2022
- Initiation Date
- Dec 6, 2021
- Termination Date
- Jun 7, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3930 bags
Product description
PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), Single use bag for IV injection (Preservative Free), Rx Only, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT NDC 05446-1667-01
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
nationwide
Code information
08-2021-24@6 12/06/2021, 08-2021-31@7 12/12/2021, 09-2021-07@3 12/21/2021, 10-2021-20@2 02/02/2022 & 10-2021-28@2 02/10/2022.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0418-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026